Attached files

file filename
10-K - 10-K - Cardiff Oncology, Inc.trov-123119x10k.htm
EX-32.2 - EXHIBIT 32.2 - Cardiff Oncology, Inc.exhibit322q42019.htm
EX-32.1 - EXHIBIT 32.1 - Cardiff Oncology, Inc.exhibit321q42019.htm
EX-31.2 - EXHIBIT 31.2 - Cardiff Oncology, Inc.exhibit312q42019.htm
EX-31.1 - EXHIBIT 31.1 - Cardiff Oncology, Inc.exhibit311q42019.htm
EX-4.16 - EXHIBIT 4.16 - Cardiff Oncology, Inc.exhibit416q42019.htm


Exhibit 23.1


Consent of Independent Registered Public Accounting Firm
 
Trovagene, Inc.
San Diego, California
 
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (Nos. 333-234442, 333-233568 and 333-224808), Form S-3 (Nos. 333-232321, 333-229693, 333-211705 and 333-208010) and Form S-8 (Nos. 333-232363, 333-226172, 333-220060, 333-211846, 333-205424 and 333-190415) of Trovagene, Inc. (the “Company”) of our report dated February 27, 2020, relating to the financial statements, which appears in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
 
/s/ BDO USA, LLP
 
San Diego, California
February 27, 2020